[go: up one dir, main page]

FI72318C - Förfarande för framställning av selektivt på histaminreseptorer verkan de N-/2-///5-(dimetylamino)metyl-2-furanyl/metyl/tio/etyl-N'-metyl-2-n itro-1,1-etendiamin. - Google Patents

Förfarande för framställning av selektivt på histaminreseptorer verkan de N-/2-///5-(dimetylamino)metyl-2-furanyl/metyl/tio/etyl-N'-metyl-2-n itro-1,1-etendiamin. Download PDF

Info

Publication number
FI72318C
FI72318C FI772264A FI772264A FI72318C FI 72318 C FI72318 C FI 72318C FI 772264 A FI772264 A FI 772264A FI 772264 A FI772264 A FI 772264A FI 72318 C FI72318 C FI 72318C
Authority
FI
Finland
Prior art keywords
methyl
formula
dimethylamino
furanyl
thio
Prior art date
Application number
FI772264A
Other languages
English (en)
Finnish (fi)
Other versions
FI772264A (sv
FI72318B (fi
Inventor
Barry John Price
John Watson Clitherow
John Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI72318(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Publication of FI772264A publication Critical patent/FI772264A/fi
Priority to FI821570A priority Critical patent/FI80687C/sv
Application granted granted Critical
Publication of FI72318B publication Critical patent/FI72318B/fi
Publication of FI72318C publication Critical patent/FI72318C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI772264A 1976-08-04 1977-07-22 Förfarande för framställning av selektivt på histaminreseptorer verkan de N-/2-///5-(dimetylamino)metyl-2-furanyl/metyl/tio/etyl-N'-metyl-2-n itro-1,1-etendiamin. FI72318C (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI821570A FI80687C (sv) 1976-08-04 1982-05-05 2-///5-(Dimetylamino)metyl-2-furanyl/metyl/tio/etanamin

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB3246576 1976-08-04
GB5068576 1976-12-06
GB5068576 1976-12-06
GB2018777 1977-05-13
GB2018777 1977-05-13
KR770001808 1977-08-04
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (3)

Publication Number Publication Date
FI772264A FI772264A (sv) 1978-02-05
FI72318B FI72318B (fi) 1987-01-30
FI72318C true FI72318C (sv) 1987-05-11

Family

ID=27448487

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772264A FI72318C (sv) 1976-08-04 1977-07-22 Förfarande för framställning av selektivt på histaminreseptorer verkan de N-/2-///5-(dimetylamino)metyl-2-furanyl/metyl/tio/etyl-N'-metyl-2-n itro-1,1-etendiamin.

Country Status (16)

Country Link
AT (1) AT375931B (sv)
CH (2) CH642072A5 (sv)
CY (1) CY1077A (sv)
DE (2) DE2759959C2 (sv)
DK (2) DK148258C (sv)
ES (2) ES461334A1 (sv)
FI (1) FI72318C (sv)
HK (1) HK55780A (sv)
IE (1) IE45456B1 (sv)
IT (2) IT1126759B (sv)
KE (1) KE3080A (sv)
NZ (2) NZ184759A (sv)
PH (1) PH13540A (sv)
PT (1) PT66874B (sv)
SE (3) SE437373B (sv)
YU (2) YU40006B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (sh) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj POSTUPAK ZA sintezu N-[2[[[5=[(DIALKILAMINO)METIL]-2= FURANIL]METIL]TIO]ETIL]-N'-ALKIL-2-NITRO 1,1 ALKENDIAMINA I NJIHOVIH HIDROHLORIDA

Also Published As

Publication number Publication date
DK149952C (da) 1987-07-06
SE454882B (sv) 1988-06-06
SE437373B (sv) 1985-02-25
IT8548437A0 (it) 1985-08-01
AT375931B (de) 1984-09-25
ATA574077A (de) 1984-02-15
CH641176A5 (en) 1984-02-15
IE45456L (en) 1978-02-04
FI772264A (sv) 1978-02-05
IE45456B1 (en) 1982-08-25
DE2760097C2 (sv) 1989-08-17
YU200082A (en) 1983-01-21
DK149952B (da) 1986-11-03
DE2759959C2 (sv) 1988-08-04
SE454883B (sv) 1988-06-06
DK416384A (da) 1984-08-30
DK148258B (da) 1985-05-20
KE3080A (en) 1980-10-03
DK337977A (da) 1978-02-05
SE8205533L (sv) 1982-09-28
YU40006B (en) 1985-06-30
PH13540A (en) 1980-06-26
SE8205533D0 (sv) 1982-09-28
SE7708521L (sv) 1978-02-05
SE8206556L (sv) 1982-11-17
CH642072A5 (en) 1984-03-30
YU191177A (en) 1983-01-21
NZ184759A (en) 1980-09-12
ES470836A1 (es) 1979-02-16
HK55780A (en) 1980-10-10
DK416384D0 (da) 1984-08-30
IT1126759B (it) 1986-05-21
CY1077A (en) 1980-12-27
ES461334A1 (es) 1979-05-16
FI72318B (fi) 1987-01-30
PT66874B (en) 1979-01-23
IT1221058B (it) 1990-06-21
DK148258C (da) 1985-10-14
YU40088B (en) 1985-06-30
SE8206556D0 (sv) 1982-11-17
NZ191383A (en) 1980-09-12
PT66874A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
JPS5840956B2 (ja) アミノアルキルフラン誘導体、その製法およびそれを含有する医薬組成物
SU1184443A3 (ru) Способ получени производных тиазола (его варианты)
EP0002930B1 (en) Amine derivatives, their preparation and pharmaceutical compositions containing them
DE69215965T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
GB1601459A (en) Aminoalkyl thiophene derivatives
IE46886B1 (en) Aminoalkyl-benzene derivatives
KR850001884B1 (ko) 수용성 벤조티아진 디옥시드염류의 제조방법
AU747448B2 (en) 2,4 Bis{(4-amidino)phenyl}furans as anti-Pneumocystis Carini agents
FI72318C (sv) Förfarande för framställning av selektivt på histaminreseptorer verkan de N-/2-///5-(dimetylamino)metyl-2-furanyl/metyl/tio/etyl-N'-metyl-2-n itro-1,1-etendiamin.
JPH0338269B2 (sv)
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
CA1185611A (en) Furan derivatives and addition salts thereof and processes for the preparation thereof
US4431664A (en) Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom
SU816402A3 (ru) Способ получени аминопроизводных2-МЕТил-5-(2-ОКСиСТиРил)-1,3,4-ТиА-диАзОлА или иХ СОлЕй
US4537968A (en) Thiophene derivatives with antisecretory activity
FI77027C (sv) Sätt framställning av farmakologiskt verksam 1-/1-(3,4-dimetoxifenyl) -3-amino-propyl/-6,7-dimetoxi-isokinolinförening.
NO149546B (no) Analogifremgangsmaate for fremstilling av et nytt, terapeutisk aktivt aminoalkylfuran-derivat
KR840001967B1 (ko) 1,1,3,5-치환 뷰렛 화합물의 제조방법
DK149812B (da) Analogifremgangsmaade til fremstilling af aminoalkylfuranderivater
PL91716B1 (sv)
Tandon et al. Anti-inflammatory, analgesic and antiproteolytic activities of some novel thiadiazoles
JPS58213768A (ja) フラン誘導体およびそれらの付加塩、それらの製法、薬剤組成物、ならびにそれらの治療への使用
DD298100A5 (de) Aminoalkylfuranderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH651560A5 (en) Aminoalkylfuran derivatives, and drugs containing these compounds

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: ALLEN & HANBURYS LIMITED